135
Views
89
CrossRef citations to date
0
Altmetric
Original Article

Uveitis in Behçet's Disease

Pages 67-79 | Received 07 Aug 1995, Published online: 10 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (9)

Antonio Vitale, Valeria Caggiano, Virginia Berlengiero, Maria Orsetta Perfetti, Jurgen Sota, Gian Marco Tosi, Bruno Frediani, Luca Cantarini & Claudia Fabiani. (2023) Comparing biologic options for the management of Behcet’s disease-related uveitis. Expert Review of Clinical Immunology 19:3, pages 315-328.
Read now
Imen Ksiaa, Nesrine Abroug, Anis Mahmoud, Hager Ben Amor, Sonia Attia, Sana Khochtali & Moncef Khairallah. (2021) Hypopyon: Is-it Infective or Noninfective?. Ocular Immunology and Inflammation 29:4, pages 817-829.
Read now
Shintaro Shirahama, Toshikatsu Kaburaki, Junko Matsuda, Rie Tanaka, Hisae Nakahara, Keiko Komae, Hidetoshi Kawashima & Makoto Aihara. (2020) The Relationship between Fluorescein Angiography Leakage after Infliximab Therapy and Relapse of Ocular Inflammatory Attacks in Ocular Behçet’s Disease Patients. Ocular Immunology and Inflammation 28:8, pages 1166-1170.
Read now
Semra Koca, Duru Onan, Defne Kalaycı & Nuran Allı. (2020) Comparison of Optical Coherence Tomography Angiography Findings in Patients with Behçet’s Disease and Healthy Controls. Ocular Immunology and Inflammation 28:5, pages 806-813.
Read now
Jennifer S Harthan, Dominick L Opitz, Stephanie R Fromstein & Christina E Morettin. (2016) Diagnosis and treatment of anterior uveitis: optometric management. Clinical Optometry 8, pages 23-35.
Read now
Ryo Rokutanda, Mitsumasa Kishimoto & Masato Okada. (2015) Update on the diagnosis and management of Behçet’s disease. Open Access Rheumatology: Research and Reviews 7, pages 1-8.
Read now
Abdullah Özkiris. (2006) Intravitreal Triamcinolone Acetonide Injection for the Treatment of Posterior Uveitis. Ocular Immunology and Inflammation 14:4, pages 233-238.
Read now
Cem Evereklioglu. (2004) Managing the symptoms of Behçet’s disease. Expert Opinion on Pharmacotherapy 5:2, pages 317-328.
Read now
Tsuyoshi Sakane & Mitsuhiro Takeno. (2000) Novel approaches to Behçet’s disease. Expert Opinion on Investigational Drugs 9:9, pages 1993-2005.
Read now

Articles from other publishers (80)

Isha Samreen, Puja Darji, Satchel Genobaga, Saivishnu Doosetty, Tamanna Mohta, Gargi Maity, Chong Vue, Sriharsha Nakka & Chukwuemeka Umeh. (2023) Pulmonary Artery Aneurysm in Behcet Disease: Medical, Endovascular or Surgical Intervention. Cureus.
Crossref
Fadi Hassan, Helana Jeries & Mohammad E. Naffaa. (2023) Challenges in the Timely Diagnosis of Behcet’s Disease. Life 13:5, pages 1157.
Crossref
Se Rim Choi, Joo Young Shin, Anna Shin, Hokyung Choung, Se Joon Woo, Sang Jun Park, You-Jung Ha, Yun Jong Lee, Eun Bong Lee, Jin Kyun Park & Eun Ha Kang. (2023) Comparative risk of blindness and vision-threatening ocular comorbidities in patients with Behçet’s disease versus the general population. Rheumatology 62:5, pages 1895-1902.
Crossref
Wafae Akioud, Abderrahmane Hamzi, Mehdi Khamaily, Yassine Mozari & Abdelbarre Oubaaz. (2022) Macular Complications of Behcet Disease: What to Expect?. European Journal of Medical and Health Sciences 4:6, pages 29-31.
Crossref
Hadas Samuels, Malki Malov, Trishna Saha Detroja, Karin Ben Zaken, Naamah Bloch, Meital Gal-Tanamy, Orly Avni, Baruh Polis & Abraham O. Samson. (2022) Autoimmune Disease Classification Based on PubMed Text Mining. Journal of Clinical Medicine 11:15, pages 4345.
Crossref
Eisha K. Multani, Dalvir Bajwa, Priyanika K. Multani, Ehsan Nobakht, Dominic Raj & Rohan S. Paul. (2022) Eye disease in kidney transplantation: Clinical challenges in a unique patient population. Survey of Ophthalmology 67:4, pages 1252-1269.
Crossref
Wendy M. Smith & Heba T. Rihani. 2022. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology 4227 4262 .
S. Masmejan, Y. Guex-Crosier, C. Diserens, M. Vouga, A. S. Clottu, C. Ribi, P. Mathevet & M. Jacot-Guillarmod. (2021) When obstetrics–gynecology specialists need to call an ophthalmologist urgently: a case report. Journal of Medical Case Reports 15:1.
Crossref
Jessica A. Walsh & Marina Magrey. (2021) Clinical Manifestations and Diagnosis of Axial Spondyloarthritis. JCR: Journal of Clinical Rheumatology 27:8, pages e547-e560.
Crossref
Hiroshi Keino, Takayo Watanabe, Makiko Nakayama, Yoshinori Komagata, Kazuhito Fukuoka & Annabelle A Okada. (2021) Long-term efficacy of early infliximab-induced remission for refractory uveoretinitis associated with Behçet’s disease. British Journal of Ophthalmology 105:11, pages 1525-1533.
Crossref
Yasutsugu Ida, Masaki Takeuchi, Mami Ishihara, Etsuko Shibuya, Takahiro Yamane, Yukiko Hasumi, Shigeru Kawano, Ikuko Kimura & Nobuhisa Mizuki. (2021) An open-label, prospective, single-arm study of switching from infliximab to cyclosporine for refractory uveitis in patients with Behçet’s disease in long-term remission. Japanese Journal of Ophthalmology 65:6, pages 843-848.
Crossref
Julie Francois, Thomas Moulinet, Estelle Neiter, Alix Ehrardt, Jean-Baptiste Conart & Karine Angioi-Duprez. (2021) Maladie de Behçet : description et analyse d’une série rétrospective monocentrique française de 51 patients. Journal Français d'Ophtalmologie 44:5, pages 711-717.
Crossref
Maria Teresa Vargas Cuervo, Diego Fernando Severiche Bueno, Humberto Carlo Parra Bonilla & Andres Montaño Rozo. (2021) Enfermedad de Behçet vs enfermedad inflamatoria intestinal. Diferencias en la presentación clínica. Revista colombiana de Gastroenterología 36:1, pages 98-102.
Crossref
D. Saadouli, A. Lahmar, K. Ben Mansour, N. El Afrit, S. Yahyaoui & M.A. El Afrit. (2021) Les manifestations oculaires au cours de la maladie de Behçet. Journal Français d'Ophtalmologie 44:2, pages 196-202.
Crossref
Noe Horiguchi, Koju Kamoi, Shintaro Horie, Yuko Iwasaki, Hisako Kurozumi-Karube, Hiroshi Takase & Kyoko Ohno-Matsui. (2020) A 10-year follow-up of infliximab monotherapy for refractory uveitis in Behçet’s syndrome. Scientific Reports 10:1.
Crossref
Tim B. van der Houwen, Jan A. M. van Laar, Jasper H. Kappen, Petrus M. van Hagen, Marcel R. de Zoete, Guus H. van Muijlwijk, Roos-Marijn Berbers, Ad C. Fluit, Malbert Rogers, James Groot, C. Marijn Hazelbag, Clarissa Consolandi, Marco Severgnini, Clelia Peano, Mario M. D'Elios, Giacomo Emmi & Helen L. Leavis. (2020) Behçet's Disease Under Microbiotic Surveillance? A Combined Analysis of Two Cohorts of Behçet's Disease Patients. Frontiers in Immunology 11.
Crossref
Wendy M. Smith & Heba T. Rihani. 2020. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology 1 37 .
Ouafa Sijilmassi. (2019) Folic acid deficiency and vision: a review. Graefe's Archive for Clinical and Experimental Ophthalmology 257:8, pages 1573-1580.
Crossref
I. Ksiaa, N. Abroug, M. Kechida, S. Zina, B. Jelliti, S. Khochtali, S. Attia & M. Khairallah. (2019) Œil et maladie de Behçet. Journal Français d'Ophtalmologie 42:6, pages 626-641.
Crossref
Necmettin Akdeniz, Ömer Faruk Elmas & Ayşe Serap Karadağ. (2019) Behçet syndrome: A great imitator. Clinics in Dermatology 37:3, pages 227-239.
Crossref
I. Ksiaa, N. Abroug, M. Kechida, S. Zina, B. Jelliti, S. Khochtali, S. Attia & M. Khairallah. (2019) Eye and Behçet's disease. Journal Français d'Ophtalmologie 42:4, pages e133-e146.
Crossref
Ji Hwan Lee, Christopher Seungkyu Lee & Sung Chul Lee. (2018) Interferon alpha-2a treatment for refractory Behcet uveitis in Korean patients. BMC Ophthalmology 18:1.
Crossref
Ai Kido, Akihito Uji, Satoshi Morooka, Yoshimasa Kuroda, Shigeta Arichika, Tadamichi Akagi & Akitaka Tsujikawa. (2018) Outer Plexiform Layer Elevations as a Marker for Prior Ocular Attacks in Patients With Behcet's Disease. Investigative Opthalmology & Visual Science 59:7, pages 2828.
Crossref
Thomas W. McNally, Erika M. Damato, Philip I. Murray, Alastair K. Denniston & Robert J. Barry. (2017) An update on the use of biologic therapies in the management of uveitis in Behçet’s disease: a comprehensive review. Orphanet Journal of Rare Diseases 12:1.
Crossref
Alireza Sadeghi, Fereydoun Davatchi, Farhad Shahram, Arezoo Karimimoghadam, Majid Alikhani, Aiyoub Pezeshgi, Saeideh Mazloomzadeh, Bahar Sadeghi-Abdollahi & Masoud Asadi-Khiavi. (2017) Serum Profiles of Cytokines in Behcet’s Disease. Journal of Clinical Medicine 6:5, pages 49.
Crossref
Z. S. Alekberova, E. A. Denisova, G. A. Davydova, Z. R. Khatagova & M. V. Ryabina. (2017) LATE DIAGNOSIS OF UVEITIS IN A GIRL WITH BEHСET'S DISEASE: DEMONSTRATION OF A CLINICAL CASE. Rheumatology Science and Practice 54:6, pages 712-714.
Crossref
T. A. Lisitsyna, G. A. Davydova, Z. R. Khatagova, L. A. Katargina & Z. S. Alekberova. (2017) EVALUATION OF UVEITIS ACTIVITY USING BOS24 IN PATIENTS WITH BEHСET'S DISEASE. Rheumatology Science and Practice 54:6, pages 681-686.
Crossref
Karolyn A. Wanat, Benjamin Kim & Misha Rosenbach. (2016) Multisystem diseases affecting the skin and eye. Clinics in Dermatology 34:2, pages 214-241.
Crossref
Masaru Takeuchi, Kozo Harimoto, Manzo Taguchi & Yutaka Sakurai. (2015) Reconstitution of disrupted photoreceptor layer in uveitis associated with Behçet’s disease by infliximab treatment. BMC Ophthalmology 15:1.
Crossref
Izumi Kurata, Hiroto Tsuboi, Hidenori Takahashi, Saori Abe, Hiroshi Ebe, Shinya Hagiwara, Naoto Umeda, Yuya Kondo, Hiroshi Ogishima, Takeshi Suzuki, Isao Matsumoto, Sujin Hoshi, Tetsuro Oshika & Takayuki Sumida. (2015) Successful Treatment with Infliximab for Refractory Uveitis in a Hemodialysis Patient with Behçet's Disease and a Review of the Literature for Infliximab Use in Patients on Hemodialysis. Internal Medicine 54:12, pages 1553-1557.
Crossref
Toshikatsu Kaburaki. 2015. Behçet's Disease. Behçet's Disease 55 78 .
H Keino, A A Okada, T Watanabe & W Taki. (2014) Long-term efficacy of infliximab on background vascular leakage in patients with Behçet’s disease. Eye 28:9, pages 1100-1106.
Crossref
Vijay Vishwanath, Ericka Wong, Sara C. Crystal, Matthew S. Robbins, Maria Filopoulos, Richard B. Lipton, Yusuf Yazici & Ilya Kister. (2014) Headache in Behçet’s Syndrome: Review of Literature and NYU Behçet’s Syndrome Center Experience. Current Pain and Headache Reports 18:9.
Crossref
Ahmed Allam, Hatem Ammar & Abdullah Radwan. (2014) Serum homocysteine level and eye involvement in Egyptian patients with Behçet’s disease. The Egyptian Rheumatologist 36:1, pages 29-34.
Crossref
Tatsushi Kawaguchi, Yuko Kawazoe, Koju Kamoi, Masaru Miyanaga, Hiroshi Takase, Sunao Sugita & Manabu Mochizuki. (2013) Clinical course of patients with Behçet’s uveitis following discontinuation of infliximab therapy. Japanese Journal of Ophthalmology 58:1, pages 75-80.
Crossref
M. Khairallah, S. Ben Yahia, R. Kahloun, I. Khairallah-Ksiaa & R. Messaoud. (2012) Œil et maladie de Behçet. Journal Français d'Ophtalmologie 35:10, pages 826-837.
Crossref
Atsuhiro Kanda, Kousuke Noda, Yuichi Oike & Susumu Ishida. (2012) Angiopoietin-like protein 2 mediates endotoxin-induced acute inflammation in the eye. Laboratory Investigation 92:11, pages 1553-1563.
Crossref
A. Arroul-Lammali, Z. Djeraba, M. Belkhelfa, H. Belguendouz, D. Hartani, O.S. Lahlou-Boukoffa & C. Touil-Boukoffa. (2012) Early involvement of nitric oxide in mechanisms of pathogenesis of experimental autoimmune uveitis induced by interphotoreceptor retinoid-binding protein (IRBP). Journal Français d'Ophtalmologie 35:4, pages 251-259.
Crossref
Simon R.J. Taylor, Jasmin Singh, Victor Menezo, Denis Wakefield, Peter McCluskey & Sue Lightman. (2011) Behçet Disease: Visual Prognosis and Factors Influencing the Development of Visual Loss. American Journal of Ophthalmology 152:6, pages 1059-1066.
Crossref
Simone Appenzeller & Elizabeth Hazel. (2009) Pentoxifylline for the treatment of anterior uveitis in Behcet’s disease: possible alternative for TNF blockers. Rheumatology International 31:11, pages 1511-1513.
Crossref
Sophie Plainer & Yosuf El-Shabrawi. (2012) Uveitis bei rheumatischen Erkrankungen. rheuma plus 10:3, pages 25-30.
Crossref
Houda BelguendouzDjamel MessaoudèneKarima LahmarLaid AhmediOsama MedjeberDahbia HartaniOuidad Lahlou-BoukoffaChafia Touil-Boukoffa. (2011) Interferon-γ and Nitric Oxide Production During Behçet Uveitis: Immunomodulatory Effect of Interleukin-10. Journal of Interferon & Cytokine Research 31:9, pages 643-651.
Crossref
Steven Yeh, Wai L. Lee, Richard B. Rosenbaum & James T. Rosenbaum. (2011) Hearing loss, uveomeningitis, and stroke in a 55‐year‐old man. Arthritis Care & Research 63:2, pages 298-306.
Crossref
M. Khairallah, R. Messaoud & S. Ben Yahia. (2011) Œil et maladie de Behçet. EMC - Ophtalmologie 8:4, pages 1-15.
Crossref
David C. Herman. 2011. Cornea. Cornea 1299 1305 .
AnnaRita Giardina, Angelo Ferrante, Francesco Ciccia, Maria Vadalà, Ennio Giardina & Giovanni Triolo. (2009) One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet’s disease refractory to standard immunosuppressive drugs. Rheumatology International 31:1, pages 33-37.
Crossref
N Unoki, K Nishijima, M Kita, R Hayashi & N Yoshimura. (2009) Structural changes of fovea during remission of Behçet's disease as imaged by spectral domain optical coherence tomography. Eye 24:6, pages 969-975.
Crossref
Ali A. Zaidi, Gui-Shuang Ying, Ebenezer Daniel, Sapna Gangaputra, James T. Rosenbaum, Eric B. Suhler, Jennifer E. Thorne, C. Stephen Foster, Douglas A. Jabs, Grace A. Levy-Clarke, Robert B. Nussenblatt & John H. Kempen. (2010) Hypopyon in Patients with Uveitis. Ophthalmology 117:2, pages 366-372.
Crossref
Y. Lachkar, E. Brasnu & I. Orignac. 2010. Les Uvéites. Les Uvéites 695 711 .
Karla L. Miller & Grant W. Cannon. 2010. Targeted Treatment of the Rheumatic Diseases. Targeted Treatment of the Rheumatic Diseases 238 248 .
Kenneth J. Warrington & Leslie T. CooperJr.Jr.. 2010. Rutherford's Vascular Surgery. Rutherford's Vascular Surgery 1156 1168 .
Yasemin Ozdamar, Nilufer Berker, Gul Bahar, Emel Soykan, Tolga Bicer, Seyhan Sonar Ozkan & Jale Karakaya. (2018) Inflammatory mediators and posterior segment involvement in ocular Behçet disease. European Journal of Ophthalmology 19:6, pages 998-1003.
Crossref
Natalia Fernández-Chico, Beatriz Artigas & Manuel Monteagudo. (2008) Enfermedad de Behçet. Piel 23:8, pages 421-427.
Crossref
L. El Fekih, N. Khaldi, W. Hmaied, I. Ksantini, A. Mestiri & M. Doggi. (2007) Occlusions veineuses rétiniennes et maladie de Behçet. La Revue de Médecine Interne 28:11, pages 742-745.
Crossref
Ufuk Elgin, Nilufer Berker, Aygen Batman & Emel Soykan. (2007) Trabeculectomy With Mitomycin C in Secondary Glaucoma Associated With Behçet Disease. Journal of Glaucoma 16:1, pages 68-72.
Crossref
. 2007. Augenheilkunde. Augenheilkunde 273 308 .
Raed Behbehani & Salim Al-Mutairi. (2006) Headache and vision loss in a 41-year-old man. The Lancet Neurology 5:5, pages 458-462.
Crossref
R V. PAUL CHAN, THOMAS C. LEE, R KRISHNA CHAGANTI, DEAN M. CESTARI, MARSHALL T. KIM & SANGWOO LEE. (2006) MACULAR STAR ASSOCIATED WITH BEHÇET DISEASE. Retina 26:4, pages 468-470.
Crossref
R V. PAUL CHAN, THOMAS C. LEE, R KRISHNA CHAGANTI, DEAN M. CESTARI, MARSHALL T. KIM & SANGWOO LEE. (2006) MACULAR STAR ASSOCIATED WITH BEH??ET DISEASE. Retina 26:4, pages 468-470.
Crossref
Chi-Chao Chan & Robert B. Nussenblatt. 2006. Ocular Angiogenesis. Ocular Angiogenesis 291 305 .
Sevim Kavuncu, Feray Koç, Melih Kurt, Buğra Eryüksel, Serap Ortaç, Pınar Özdal & Esin Fırat. (2005) Evaluation of serum leptin concentration in Behçet’s disease with ocular involvement. Graefe's Archive for Clinical and Experimental Ophthalmology 243:11, pages 1158-1160.
Crossref
K. Janati, K. EL Omari, H. Benchiki, M. Hamdani & H. Lakhdar. (2005) Les manifestations oculaires de la maladie de Behçet (étude de 50 patients consultant en dermatologie). La Revue de Médecine Interne 26:10, pages 771-776.
Crossref
Jennifer J. Lee, Susan Beebout, Andrew G. Lee, Rebecca Tuetken & David A. Weinberg. (2005) Blood-tinged Stools and Blood-shot Eyes. Survey of Ophthalmology 50:5, pages 476-484.
Crossref
Cem Evereklioglu. (2005) Current Concepts in the Etiology and Treatment of Behçet Disease. Survey of Ophthalmology 50:4, pages 297-350.
Crossref
Ufuk Elgin, Nilufer Berker & Aygen Batman. (2004) Incidence of Secondary Glaucoma in Beh??et Disease. Journal of Glaucoma 13:6, pages 441-444.
Crossref
Shwu-Jiuan Sheu & Cheng-An Yang. (2004) Macular Hole in Behcet's Disease. The Kaohsiung Journal of Medical Sciences 20:11, pages 558-562.
Crossref
Moncef Feki, Habib Houman, Mehdi Ghannouchi, Monia Smiti-Khanfir, Kamel Hamzaoui, Leila El Matri, Abderraouf Mebazaa & Neziha Kaabachi. (2004) Hyperhomocysteinaemia is associated with uveitis but not with deep venous thrombosis in Behçet's disease. Clinical Chemistry and Laboratory Medicine (CCLM) 42:12.
Crossref
M.C. Petrus Rivas, I. Elizalde Pérez de Ciriza, S. Millaruelo Arilla, F.J. Samper Villar, M. Batlle Bosch, F.J. Ureta Boixadera & R. Aznar Muñoz. (2004) Enfermedad de Behçet: a propósito de un caso de presentación atípica. SEMERGEN - Medicina de Familia 30:10, pages 526-528.
Crossref
D. Kane, P. V. Balint, F. Wood & R. D. Sturrock. (2003) Early diagnosis of pyomyositis using clinic-based ultrasonography in a patient receiving infliximab therapy for Behçet's disease. Rheumatology 42:12, pages 1564-1565.
Crossref
J. Banks ShepherdIIIIII. (2003) Ocular vasculitis. Current Rheumatology Reports 5:2, pages 100-106.
Crossref
Mi-Sun Kim, Hwan-Suck Chung, Jun-Gyoung Lee, Woon Ki Lim, Chung-Yeon Hwang, Eon-Jeong Lee, Kwang-Ho Cho, Dac-Han Wi & Hyung-Min Kim. (2002) Inhibition of cytokine production by the traditional oriental medicine, ‘Gamcho-Sasim-Tang’ in mitogen-stimulated peripheral blood mononuclear cells from Adamantiades-Behçet's patients. Journal of Ethnopharmacology 83:1-2, pages 123-128.
Crossref
Georges M.G.M Verjans, P Martin van Hagen, Alexander van der Kooi, Albert D.M.E Osterhaus & G Seerp Baarsma. (2002) Vγ9Vδ2 T cells recovered from eyes of patients with Behçet's disease recognize non-peptide prenyl pyrophosphate antigens. Journal of Neuroimmunology 130:1-2, pages 46-54.
Crossref
Andrew Ramsay & Susan Lightman. (2001) Hypopyon Uveitis. Survey of Ophthalmology 46:1, pages 1-18.
Crossref
Lela A. Lee. (2001) Behçet's disease. Seminars in Cutaneous Medicine and Surgery 20:1, pages 53-57.
Crossref
Fayad Hamideh & Pamela E. Prete. (2001) Ophthalmologic manifestations of rheumatic diseases. Seminars in Arthritis and Rheumatism 30:4, pages 217-241.
Crossref
A Aydintug. 2001. Vascular Manifestations of Systemic Autoimmune Diseases. Vascular Manifestations of Systemic Autoimmune Diseases.
Albert J. AugustinAlbert J. Augustin. 2001. Augenheilkunde. Augenheilkunde 263 289 .
Meir Wetzler & Nora Lincoff. (2000) Unusual Manifestations of Acute Leukemia. Journal of Clinical Oncology 18:19, pages 3439-3440.
Crossref
Tsuyoshi Sakane, Mitsuhiro Takeno, Noboru Suzuki & Goro Inaba. (1999) Behçet's Disease. New England Journal of Medicine 341:17, pages 1284-1291.
Crossref
Karl Csaky & Robert Nussenblatt. (1999) Gene therapy in the treatment of ocular inflammation. Springer Seminars in Immunopathology 21:2, pages 191-197.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.